SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 11.481
AS - Asia 5.577
EU - Europa 2.779
SA - Sud America 904
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 115
OC - Oceania 5
Totale 20.993
Nazione #
US - Stati Uniti d'America 11.208
SG - Singapore 2.112
CN - Cina 1.455
BR - Brasile 694
VN - Vietnam 635
UA - Ucraina 602
DE - Germania 591
HK - Hong Kong 464
TR - Turchia 342
GB - Regno Unito 332
IT - Italia 322
FI - Finlandia 242
FR - Francia 189
SE - Svezia 168
RU - Federazione Russa 129
MX - Messico 113
CA - Canada 109
JP - Giappone 107
IN - India 106
BD - Bangladesh 101
AR - Argentina 67
ZA - Sudafrica 57
PL - Polonia 53
IQ - Iraq 41
ID - Indonesia 38
ES - Italia 34
CO - Colombia 32
PK - Pakistan 29
BE - Belgio 27
NL - Olanda 27
EC - Ecuador 26
CL - Cile 23
VE - Venezuela 22
PE - Perù 18
PH - Filippine 18
SA - Arabia Saudita 18
LT - Lituania 17
UZ - Uzbekistan 14
MY - Malesia 13
JM - Giamaica 12
MA - Marocco 12
TN - Tunisia 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
IR - Iran 10
KE - Kenya 10
CR - Costa Rica 8
CZ - Repubblica Ceca 8
IL - Israele 8
OM - Oman 7
BO - Bolivia 6
CH - Svizzera 6
DZ - Algeria 6
HN - Honduras 6
JO - Giordania 6
EG - Egitto 5
GT - Guatemala 5
NP - Nepal 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AT - Austria 4
EU - Europa 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AU - Australia 3
AZ - Azerbaigian 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
Totale 20.860
Città #
Singapore 1.333
Ashburn 1.184
Woodbridge 962
Fairfield 942
San Jose 716
Houston 671
Jacksonville 624
Chandler 536
Santa Clara 530
Ann Arbor 485
Beijing 485
Hong Kong 455
Seattle 366
Wilmington 354
Dallas 324
Cambridge 285
Council Bluffs 266
Izmir 196
Ho Chi Minh City 190
Munich 190
New York 186
Los Angeles 185
Nanjing 184
Hanoi 158
Princeton 125
Tokyo 102
Lauterbourg 101
San Diego 94
Helsinki 93
Milan 92
Boardman 88
Buffalo 82
São Paulo 82
Mexico City 80
Shanghai 74
Bremen 61
Ferrara 58
Nanchang 53
Orem 53
Hefei 52
Montreal 48
Shenyang 48
London 47
Warsaw 46
Tianjin 43
Hebei 41
Addison 37
Changsha 37
Chicago 36
Dong Ket 33
Johannesburg 33
Chennai 32
Toronto 32
Denver 31
Atlanta 30
Brooklyn 30
San Mateo 30
Jinan 28
Turku 28
Da Nang 27
Phoenix 27
The Dalles 27
Stockholm 26
Auburn Hills 22
Haiphong 22
Mountain View 22
Poplar 22
Brussels 21
Philadelphia 21
Jiaxing 20
Frankfurt am Main 19
Manchester 19
Biên Hòa 18
Hải Dương 18
Rio de Janeiro 18
Verona 18
Boston 17
Moscow 17
Amsterdam 15
Baghdad 15
Kunming 15
Rome 15
San Francisco 15
Ankara 14
Charlotte 14
Zhengzhou 14
Augusta 13
Dearborn 13
Dhaka 13
Falkenstein 13
Medellín 13
Tappahannock 13
Bắc Ninh 12
Norwalk 12
Redwood City 12
Brasília 11
Columbus 11
Curitiba 11
Tashkent 11
Goiânia 10
Totale 14.473
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 416
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 406
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 388
A cyclic peptide T analogue with high chemotactic activity 297
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 282
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 249
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 242
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 237
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 235
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 233
Modulation of neutrophil functions by activated platelet release factors 230
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 225
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 223
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 223
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 221
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 218
Ring-opened analogs of indomethacin affecting human neutrophil functions 215
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 215
Attivita' tumoricida dei neutrofili 212
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 212
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 211
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 210
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 207
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 206
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 204
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 203
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 203
Conformational Aspects of Human Formyl-peptide Receptor Agonists 202
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 199
Modified chemotactic peptides: Synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe 197
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 197
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 194
Conformational aspects of human formylpeptide receptor antagonists 194
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 193
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 192
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 190
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 190
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 189
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 187
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 186
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 186
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 184
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 183
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 183
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 183
Oligomeric formylpeptide activity on human neutrophils 179
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 177
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 177
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 176
Probing structural requirements of fMLP receptor: On the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide 176
HLA B51 antigen associated with neutrophil hyper-reactivity 176
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 175
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 175
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 174
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 174
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 173
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 169
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 169
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 168
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 168
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 167
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 165
Synthesis and properties of chemotactic peptide analogs: II. HCO‐Met‐Leu‐Phe‐OMe analogs containing cyclic α,α‐disubstituted amino acids as Met and Phe mimicking residues 164
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 163
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 163
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'(methylthio) ethyl] methionine residue 163
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 161
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 160
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs 159
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 158
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 158
Synthesis and bioactivity of chemotactic tetrapeptides: FMLF-OMe analogues incorporating spacer aminoacids at the lateral positions 153
Protein kinase C mediates human neutrophil cytotoxicity 152
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 147
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 147
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 147
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 146
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 145
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 144
Antibody-independent cytoxicity against human erythroleukemic K 562 human cells by neutrophils 144
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 138
Valutazione funzionale dei leucociti. 137
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 135
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: The N-terminal region 135
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 134
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 134
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 132
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 127
Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+ 126
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 125
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 125
Chemotactic effects of nociceptin/orphanin FQ on human monocytes are mediated by nop receptor activation 124
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 123
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 123
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 119
Peptide T revisited: Conformational mimicry of epitopes of anti-HIV proteins 119
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 118
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 117
Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing ß-alanine or taurine at the central position 116
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 113
Totale 18.284
Categoria #
all - tutte 91.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.283
Totale 92.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.088 0 0 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20252.531 67 30 183 72 349 253 138 154 407 274 343 261
2025/20267.512 763 553 704 1.062 1.069 498 730 357 655 808 248 65
2026/2027875 201 392 282 0 0 0 0 0 0 0 0 0
Totale 20.993